Alternative pathway blockade via factor B inhibition limits C3 cleavage, amplification loop activity, and downstream membrane ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I am 81 years old and in excellent health. My blood pressure ...

Accurate assessment of renal function is critical in the management of renal cell carcinoma (RCC), influencing surgical planning, systemic therapy eligibility, and clinical trial inclusion. Estimated ...

Susceptibility to renal disease after low birth weight (LBW) is thought to be an additional dimension to the Barker hypothesis of prenatal programming of adult diseases (1,2). Inclusion criteria were ...

New research reveals that contrary toconventional belief, primary glomerular diseases are not necessarily benign for children and young adults. In fact, some subsets of children and young adults may ...

Kidney disease is common in adults, and testing for kidney disease is part of routine clinical practice for patients with acute or chronic illness. The initial evaluation includes determination of the ...

September 13, 2006 — Macroalbuminuria was a better population-screening marker than low estimated glomerular filtration rate (eGFR) or erythrocyturia to identify individuals who subsequently lost ...

No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2007 ASCO Annual Meeting. This abstract does not include a full text component.

The accuracy of estimation of kidney function with the use of routine metabolic tests, such as measurement of the serum creatinine level, has been controversial. The European Kidney Function ...

Each kidney is made up of approximately one million glomeruli. These filter nitrogenous wastes (like urea and creatinine) from the blood, passing through the tuft of capillaries that make up a ...

Please provide your email address to receive an email when new articles are posted on . Treatment of glomerular disease has a hard endpoint, Brad H. Rovin, MD, FACP, FASN, said — slowing progression ...